It upregulates the growth hormone receptor on tendon cells, so they respond more to your own circulating GH
Read the full review Cerebrovascular & Cognitive Health 14 May 2026 Dihexa for Vascular Dementia & Vascular Cognitive Impairment: The 2026 UK Review Can Dihexa help vascular dementia (VaD) or vascular cognitive impairment (VCI)
The faster and more fully you can repair muscle, connective tissue, and joints after intense training, the faster youll see gains and the less risk youll have of injury or chronic inflammation stalling your progress

Weight loss by timeframe Month 1-2 (initial titration): 5-10 lbs lost Lower doses, body adapting Some appetite suppression Establishing habits Month 3-4 (dose escalation): 10-20 lbs total lost Significant appetite reduction Noticeable changes Plateau possible, keep titrating Month 5-8 (approaching maintenance dose): 20-35 lbs total lost Near or at full dose Maximum appetite suppression Consistent weekly loss (1-3 lbs) Month 9-12 (maintenance dose): 30-50 lbs total lost Full dose combination Continued steady loss Body composition improving Month 12-18 (long-term): 40-60+ lbs total lost (or 15-25% body weight) Exceptional responders: 60-80 lbs Weight stabilizing Focus shifts to maintenance Individual variation: Starting weight matters (higher = more absolute loss) Metabolism, activity level, diet affect results Some lose faster, some slower Consistency most important Comparison to semaglutide monotherapy Semaglutide 2.4mg alone (typical): 6 months: 20-30 lbs 12 months: 30-40 lbs 18 months: 35-45 lbs Average: 10-15% body weight CagriSema combination (typical): 6 months: 25-40 lbs 12 months: 40-60 lbs 18 months: 50-70+ lbs Average: 15-25% body weight Additional benefit: 50-75% more weight loss with combination Example: 240 lb person Semaglutide alone: Lose 24-36 lbs 204-216 lbs CagriSema combo: Lose 36-60 lbs 180-204 lbs Clinically significant difference See our peptides before and after results and how long do peptides take to work

Conventional therapies like physical therapy, occupational therapy, and intravenous immunoglobulin remain important
Neuroprotection: 100-200mcg daily for ongoing brain health support, particularly in older individuals or those with oxidative stress concerns